W0021
Rabbit Muscle Apo TIM Structure: A New Paradigm for the
Active Site Loop Conformation. Ricardo Aparicio1,3,
Sérgio T. Ferreira2 and Igor Polikarpov3,
1Instituto de Física Gleb Wataghin, UNICAMP; 2Depto. de
Bioquímica Médica, UFRJ and Laboratório Nacional de Luz
Síncrotron; 3Instituto de Física de São Carlos,
USP. Brazil. Email: ipolikarpov@if.sc.usp.br .
The active site loop of triose phosphate isomerase (TIM)
exhibits a hinged-lid motion, alternating between the two well defined open and
closed conformations. Until now the closed conformation had only been observed
in holo structures of complexes with substrate analogues. Here we present the
first rabbit muscle apo TIM structure, refined to 1.5 Å, in which the
active site loop is either in the open or in the closed conformation in
different subunits. Unexpectedly, chemical interactions characteristic for holo
TIM structures are observed in the closed conformation for the apo structure
described here. Additives used during crystallization (DMSO and TRIS molecules
and Mg atoms) were modeled in the electron density maps. However, no specific
binding of these molecules is observed in the active site or lid loop regions.
To further investigate this unusual apo enzyme closed conformation, two more
rabbit muscle TIM structures, one in the same and another in a different crystal
form, were determined. They confirmed that the observed closed conformation can
not be explained by crystal contacts. To rationalize why the active site loop is
closed in the absence of ligand in one of the subunits, extensive comparison
with previously solved TIM structures was carried out, supported by the bulk of
available experimental information about enzyme kinetics and reaction mechanism
of TIM. The simultaneous observation of both open and closed lid loop
conformations in the chemically homogeneous TIM population might be related to a
persistent conformational heterogeneity of TIM in solution. Moreover, our
results strongly support the hypothesis that TIM active site loop movement is
not ligand-gated.
RA gratefully ackowledges Drs. A. M. Brzozowski, E. J. Dodson
and G. N. Murshudov (YSBL, UK). Financial support: FAPESP (RA and IP); FAPERJ
and Howard Hughes Medical Institute (STF).